ArticleO&G open2025
Prevalence of Hypertension in the Late Postpartum Period by Hypertensive Status in Pregnancy.
Article in O&G open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo better characterize how blood pressure (BP) abnormalities in pregnancy inform the risk of late postpartum hypertension by describing rates of hypertension and associated patient attributes in the late postpartum period (6 weeks-6 months) by hypertensive status during pregnancy.
methodsThis retrospective cohort study included all patients delivering within an academic health care system between 2012 and 2023. All BPs from fertilization to 6 months postpartum were obtained from the electronic medical record. Elevations in BP of two or more systolic BPs of 140 mm Hg or higher or two or more diastolic BPs of 90 mm Hg of higher were used to assign patients to one of four categories: normal BPs throughout pregnancy and delivery, elevated BPs only before 20 weeks of gestation, elevated BPs from 20 weeks through delivery hospitalization discharge, or elevated BPs throughout pregnancy. Next, BPs from late postpartum (6 weeks-6 months) were categorized per American College of Cardiology (ACC)/American Heart Association (AHA 2017 guidelines as normotensive, elevated, stage 1, or stage 2. The association of pregnancy BP status and patient clinical and demographic characteristics with the distribution of ACC/AHA stages in the late postpartum was assessed with χ
resultsOf the final population of 31,751 patients, 58.6% had normal BPs, 0.9% had elevated BPs only before 20 weeks of gestation, 35.5% had elevated BPs only at or after 20 weeks, and 5.0% had elevated BPs throughout pregnancy and delivery. Late postpartum, 60.8% were normotensive, 15.6% were elevated, 18.9% were stage 1, and 4.7% were stage 2. Patients with elevated BPs throughout pregnancy were significantly more likely to develop stage 2 hypertension late postpartum compared with those who were normotensive in pregnancy (adjusted odds ratio 23.14, 95% CI, 18.15-29.49).
conclusionNearly 40% of patients have elevated BPs in the late postpartum period, and those with elevated BPs throughout pregnancy are at highest risk of meeting criteria for stage 1 or 2 hypertension. Review of specific BPs in pregnancy may be a valuable screening tool in identifying patients at risk of BP abnormalities late postpartum.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.